BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,902 | -22.2% | 7,814 | -6.0% | 0.00% | 0.0% |
| Q2 2023 | $378,878 | -21.7% | 8,316 | -30.3% | 0.00% | -33.3% |
| Q1 2023 | $484,143 | -29.5% | 11,936 | -11.4% | 0.00% | -25.0% |
| Q4 2022 | $687,041 | -16.0% | 13,479 | -11.3% | 0.00% | -20.0% |
| Q3 2022 | $818,000 | -2.2% | 15,196 | +16.8% | 0.01% | 0.0% |
| Q2 2022 | $836,000 | -26.0% | 13,008 | -10.8% | 0.01% | 0.0% |
| Q1 2022 | $1,130,000 | -10.5% | 14,576 | -0.9% | 0.01% | -16.7% |
| Q4 2021 | $1,262,000 | +9.4% | 14,706 | +2.5% | 0.01% | 0.0% |
| Q3 2021 | $1,154,000 | -1.6% | 14,351 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $1,173,000 | -3.6% | 14,571 | +1.0% | 0.01% | -14.3% |
| Q1 2021 | $1,217,000 | -1.8% | 14,426 | -6.6% | 0.01% | 0.0% |
| Q4 2020 | $1,239,000 | -2.5% | 15,441 | -2.3% | 0.01% | -12.5% |
| Q3 2020 | $1,271,000 | -5.9% | 15,801 | +0.8% | 0.01% | -20.0% |
| Q2 2020 | $1,350,000 | +7.4% | 15,674 | +1.2% | 0.01% | 0.0% |
| Q1 2020 | $1,257,000 | -43.1% | 15,486 | -41.4% | 0.01% | -28.6% |
| Q4 2019 | $2,209,000 | +86.7% | 26,413 | +95.3% | 0.01% | +75.0% |
| Q3 2019 | $1,183,000 | -55.3% | 13,526 | -58.1% | 0.01% | -52.9% |
| Q2 2019 | $2,647,000 | -7.4% | 32,314 | -8.1% | 0.02% | -15.0% |
| Q1 2019 | $2,858,000 | +34.8% | 35,155 | +9.1% | 0.02% | +17.6% |
| Q4 2018 | $2,120,000 | -11.3% | 32,216 | +3.9% | 0.02% | 0.0% |
| Q3 2018 | $2,390,000 | +0.5% | 31,005 | -3.7% | 0.02% | -5.6% |
| Q2 2018 | $2,378,000 | +17.7% | 32,200 | +3.7% | 0.02% | +20.0% |
| Q1 2018 | $2,020,000 | -9.4% | 31,051 | -10.0% | 0.02% | -16.7% |
| Q4 2017 | $2,230,000 | +14.4% | 34,504 | +11.0% | 0.02% | +5.9% |
| Q3 2017 | $1,950,000 | +2.3% | 31,081 | -1.3% | 0.02% | 0.0% |
| Q2 2017 | $1,907,000 | +10.2% | 31,497 | -5.6% | 0.02% | +6.2% |
| Q1 2017 | $1,731,000 | +18.6% | 33,375 | +1.3% | 0.02% | +14.3% |
| Q4 2016 | $1,460,000 | +5.3% | 32,934 | +13.1% | 0.01% | +7.7% |
| Q3 2016 | $1,387,000 | +142.5% | 29,128 | +129.3% | 0.01% | +116.7% |
| Q2 2016 | $572,000 | +0.4% | 12,702 | -8.4% | 0.01% | 0.0% |
| Q1 2016 | $570,000 | -54.3% | 13,871 | -57.6% | 0.01% | -57.1% |
| Q4 2015 | $1,247,000 | +83.4% | 32,689 | +57.8% | 0.01% | +75.0% |
| Q3 2015 | $680,000 | +24.3% | 20,714 | +43.8% | 0.01% | +33.3% |
| Q2 2015 | $547,000 | -56.1% | 14,402 | -20.5% | 0.01% | -60.0% |
| Q1 2015 | $1,245,000 | -67.8% | 18,107 | -65.7% | 0.02% | -48.3% |
| Q4 2014 | $3,869,000 | +55.4% | 52,795 | +52.2% | 0.03% | -32.6% |
| Q3 2014 | $2,490,000 | -2.5% | 34,697 | -1.8% | 0.04% | -8.5% |
| Q2 2014 | $2,553,000 | -30.5% | 35,316 | -29.3% | 0.05% | -39.7% |
| Q1 2014 | $3,673,000 | +54.0% | 49,921 | +45.6% | 0.08% | -3.7% |
| Q4 2013 | $2,385,000 | +14.1% | 34,292 | +7.7% | 0.08% | +20.9% |
| Q3 2013 | $2,091,000 | +543.4% | 31,836 | +577.8% | 0.07% | +644.4% |
| Q2 2013 | $325,000 | – | 4,697 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |